CN111748623B - 肝癌患者是否复发的预测标志物及试剂盒 - Google Patents
肝癌患者是否复发的预测标志物及试剂盒 Download PDFInfo
- Publication number
- CN111748623B CN111748623B CN202010513220.XA CN202010513220A CN111748623B CN 111748623 B CN111748623 B CN 111748623B CN 202010513220 A CN202010513220 A CN 202010513220A CN 111748623 B CN111748623 B CN 111748623B
- Authority
- CN
- China
- Prior art keywords
- protein
- liver cancer
- patient
- diagnosis
- recurrence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010513220.XA CN111748623B (zh) | 2020-06-08 | 2020-06-08 | 肝癌患者是否复发的预测标志物及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010513220.XA CN111748623B (zh) | 2020-06-08 | 2020-06-08 | 肝癌患者是否复发的预测标志物及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111748623A CN111748623A (zh) | 2020-10-09 |
CN111748623B true CN111748623B (zh) | 2022-11-04 |
Family
ID=72674961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010513220.XA Active CN111748623B (zh) | 2020-06-08 | 2020-06-08 | 肝癌患者是否复发的预测标志物及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111748623B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113528670B (zh) * | 2021-08-23 | 2023-04-11 | 郑州大学第一附属医院 | 一种用于预测肝癌患者术后晚期复发风险的生物标志物及检测试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003042661A2 (en) * | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
CN106282321A (zh) * | 2015-05-26 | 2017-01-04 | 中山大学 | 由组织snoRNA组成的肝癌复发风险预测标志物及试剂盒 |
CN108107219A (zh) * | 2017-11-30 | 2018-06-01 | 深圳市老年医学研究所 | 基于唾液蛋白质组学的肝癌肾阴虚证生物标志物检测的方法 |
CN108287242A (zh) * | 2017-11-30 | 2018-07-17 | 深圳市老年医学研究所 | 基于唾液蛋白质组学的肝癌肝郁证生物标志物检测的方法 |
CN110499364A (zh) * | 2019-07-30 | 2019-11-26 | 北京凯昂医学诊断技术有限公司 | 一种用于检测扩展型遗传病全外显子的探针组及其试剂盒和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974667B2 (en) * | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
US20140045915A1 (en) * | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
GB201320061D0 (en) * | 2013-11-13 | 2013-12-25 | Electrophoretics Ltd | Materials nad methods for diagnosis and prognosis of liver cancer |
-
2020
- 2020-06-08 CN CN202010513220.XA patent/CN111748623B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003042661A2 (en) * | 2001-11-13 | 2003-05-22 | Protein Design Labs, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
CN106282321A (zh) * | 2015-05-26 | 2017-01-04 | 中山大学 | 由组织snoRNA组成的肝癌复发风险预测标志物及试剂盒 |
CN108107219A (zh) * | 2017-11-30 | 2018-06-01 | 深圳市老年医学研究所 | 基于唾液蛋白质组学的肝癌肾阴虚证生物标志物检测的方法 |
CN108287242A (zh) * | 2017-11-30 | 2018-07-17 | 深圳市老年医学研究所 | 基于唾液蛋白质组学的肝癌肝郁证生物标志物检测的方法 |
CN110499364A (zh) * | 2019-07-30 | 2019-11-26 | 北京凯昂医学诊断技术有限公司 | 一种用于检测扩展型遗传病全外显子的探针组及其试剂盒和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN111748623A (zh) | 2020-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yu et al. | Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification | |
Zhang et al. | Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient | |
US20090204334A1 (en) | Lung cancer biomarkers | |
US9933429B2 (en) | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof | |
US8518654B2 (en) | Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect | |
Shevchenko et al. | Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry | |
Lu et al. | Detection and identification of serum peptides biomarker in papillary thyroid cancer | |
EP3257953A1 (en) | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy | |
Liu et al. | Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry | |
Liang et al. | Lipidomics analysis based on liquid chromatography mass spectrometry for hepatocellular carcinoma and intrahepatic cholangiocarcinoma | |
Zheng et al. | Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS | |
US20070087392A1 (en) | Method for diagnosing head and neck squamous cell carcinoma | |
CN111748623B (zh) | 肝癌患者是否复发的预测标志物及试剂盒 | |
CN116879558B (zh) | 卵巢癌诊断标志物、检测试剂及检测试剂盒 | |
CN111273023B (zh) | 一种肺腺癌肿瘤标记物蛋白及其应用 | |
Junker et al. | Identification of protein pattern in kidney cancer using ProteinChip® arrays and bioinformatics | |
Song et al. | MALDI‐TOF‐MS analysis in low molecular weight serum peptidome biomarkers for NSCLC | |
CN111748624B (zh) | 用于预测肝癌是否复发的生物标志物 | |
CN111751551B (zh) | 蛋白分子作为诊断肝硬化的生物标志物及其预后方法 | |
CN1851455A (zh) | 一种肿瘤标志物-血清蛋白指纹图谱的检测方法 | |
Papachristou et al. | Serum proteomic patterns as a predictor of severity in acute pancreatitis | |
Qian et al. | SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer | |
CN114609389A (zh) | 一种基于znf326蛋白作为ii期结直肠癌疗效预测标志物的方法 | |
CN111751550B (zh) | 肝癌诊断的生物标志物及其预后方法 | |
CN111751549A (zh) | 蛋白分子在肝癌诊断中的预后方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230404 Address after: Room 102, Management Office, Floor 1, Building 3, the Taihu Lake New Town Science and Technology Innovation Park, No. 18, Suzhou River Road, East the Taihu Lake Ecological Tourism Resort (the Taihu Lake New Town), Wujiang District, Suzhou City, Jiangsu Province, 215200 Patentee after: Phoenix Intelligent Pharmaceutical Biotechnology (Suzhou) Co.,Ltd. Address before: 450000 East Construction Road No. 50, Erqi District, Zhengzhou City, Henan Province Patentee before: THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU University |